Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Suzanne K. Robinson
Observed names:
S. Robinson,
Suzanne Robinson
Institution:
Bristol-Myers Squibb (Switzerland)
Observed institutions:
Celgene (Switzerland),
Celgene (United States),
Bristol-Myers Squibb (Switzerland)
OpenAlex ID:
A5020622667
Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis
2019
·
Karthik Ramasamy
, Sujith Dhanasiri
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
11
PDF
Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients
2020
·
Andrew Belch
, Nizar Bahlis
, et al.
·
Cancer Medicine
·
3
PDF
Impact of lenalidomide-bortezomib-dexamethasone (RVd) induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect MM Registry.
2020
·
Sikander Ailawadhi
, Hans Chulhee Lee
, et al.
·
Journal of Clinical Oncology
·
2
Pf637 Efficacy of Lenalidomide and Low‐dose Dexamethasone in Newly Diagnosed Patients With Multiple Myeloma: Results From a Meta‐analysis of Randomized Controlled Trial Evidence
2019
·
S. Manier
, S. Robinson
, et al.
·
HemaSphere
·
2
Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients: Meta-analysis of Efficacy in Pivotal Randomized Controlled Trials
2019
·
Salomon Manier
, Suzanne Robinson
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Experience with Long-Term Lenalidomide (LEN) Treatment in the Clinical Setting: Results From the UK Revlimid® Treatment Continuation Scheme™ (TCS)
2012
·
Cathy D. Williams
, Mathew Simcock
, et al.
·
Blood
·
1
Characterization of Relapse and Second-Line Therapy in Lenalidomide-Refractory, Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Subanalysis of the Phase 3 First Trial
2019
·
Salmon Manier
, Meletios A. Dimopoulos
, et al.
·
Blood
Phase 3 FIRST Trial in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Subgroup Analysis of Patients From Canada and the United States
2019
·
Andrew Belch
, Nizar J. Bahlis
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma.
2012
·
Guillemette Fouquet
, Stéphanie Tardy
, et al.
·
Blood
Show more works
View as search
Works count:
9
Citation count:
20
H-index:
2
I10-index:
1
Year
Topic
Type
